ICON Public Limited Company (ICLR)
Market Cap | 23.48B |
Revenue (ttm) | 8.33B |
Net Income (ttm) | 714.43M |
Shares Out | 82.82M |
EPS (ttm) | 8.61 |
PE Ratio | 32.94 |
Forward PE | 17.57 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 1,378,664 |
Open | 283.00 |
Previous Close | 288.64 |
Day's Range | 277.88 - 289.29 |
52-Week Range | 222.32 - 347.72 |
Beta | 1.22 |
Analysts | Strong Buy |
Price Target | 349.60 (+23.32%) |
Earnings Date | Oct 23, 2024 |
About ICLR
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient a... [Read more]
Financial Performance
In 2023, ICLR's revenue was $8.12 billion, an increase of 4.89% compared to the previous year's $7.74 billion. Earnings were $612.34 million, an increase of 21.18%.
Financial StatementsAnalyst Forecast
According to 10 analysts, the average rating for ICLR stock is "Strong Buy." The 12-month stock price forecast is $349.6, which is an increase of 23.32% from the latest price.
News
Icon PLC (ICLR) Trading 3.72% Higher on Oct 2
Shares of Icon PLC (ICLR, Financial) surged 3.72% in mid-day trading on Oct 2. The stock reached an intraday high of $295.09, up from its previous close of $284.51.
ICON plc Schedules Third Quarter 2024 Earnings Conference Call
DUBLIN--(BUSINESS WIRE)--ICON plc Schedules Third Quarter 2024 Earnings Conference Call.
ICON plc to Present at the Baird 2024 Global Healthcare Conference
DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the Baird 2024 Global Healthcare Conference.
ICON Public Limited Company (ICLR) Q2 2024 Earnings Call Transcript
ICON Public Limited Company (NASDAQ:ICLR) Q2 2024 Earnings Conference Call July 25, 2024 8:00 AM ET Company Participants Kate Haven - Vice President of Investor Relations Steve Cutler - Chief Executi...
ICON Reports Second Quarter 2024 Results
DUBLIN--(BUSINESS WIRE)--ICON Reports Second Quarter 2024 Results.
ICON announces results of Annual General Meeting and changes to the Board of Directors
DUBLIN--(BUSINESS WIRE)--ICON announces results of Annual General Meeting and changes to the Board of Directors.
Growing Earnings and Cash Flow Have Icon Thriving
Increasing earnings and a big cash hoard have Icon PLC (ICLR) well positioned for growth.
ICON: Deleveraging Complete, Now See 18% CAGR In Valuation To FY'26E (Rating Upgrade)
ICON acquired PRA Health Sciences in a $12B deal in 2020, creating a new company. The stock has doubled since the acquisition, and could be worth $370-$400/share based on earnings estimates and excess...
ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading busin...
ICON plc Schedules Second Quarter 2024 Earnings Conference Call
DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second ...
ICON plc to Present at the Jefferies Global Healthcare Conference
DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the Jefferies Global Healthcare Conference.
ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance
DUBLIN--(BUSINESS WIRE)--ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance.
ICON plc to hold Investor Day Meeting on May 30, 2024
DUBLIN--(BUSINESS WIRE)--ICON plc to hold Investor Day Meeting on May 30, 2024.
ICON releases its ICON Cares 2023 Report
DUBLIN--(BUSINESS WIRE)--ICON releases its ICON Cares 2023 Report.
ICON Announces Pricing of USD 2 Billion Notes
DUBLIN--(BUSINESS WIRE)--ICON Announces Pricing of USD 2 Billion Notes.
ICON Reports First Quarter 2024 Results
DUBLIN--(BUSINESS WIRE)--ICON Reports First Quarter 2024 Results.
Eight stock picks in AI, obesity drugs, e-commerce and other growth areas beyond the S&P 500
It is understandable for U.S. investors to be focused on the largest technology companies that have driven such strong performance for the S&P 500 over the past decade. But learning about strategies t...
ICON Announces CFO Transition
DUBLIN--(BUSINESS WIRE)--ICON Announces CFO Transition.
ICON plc Schedules First Quarter 2024 Earnings Conference Call
DUBLIN--(BUSINESS WIRE)--ICON plc Schedules First Quarter 2024 Earnings Conference Call.
ICON plc to Present at Upcoming Investor Conferences
DUBLIN--(BUSINESS WIRE)--ICON plc to Present at Upcoming Investor Conferences.
ICON Public Limited Company (ICLR) Q4 2023 Earnings Call Transcript
ICON Public Limited Company (ICLR) Q4 2023 Earnings Call Transcript
ICON Reports Fourth Quarter and Full Year 2023 Results
DUBLIN--(BUSINESS WIRE)--ICON Reports Fourth Quarter and Full Year 2023 Results.
ICON: Will The Huge Acquisition Of PRA Continue To Create Synergies?
ICON Public is a global clinical research organization that provides services for the pharmaceutical, biotechnology, and medical device industries. The clinical research organization sector is expecte...
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
DUBLIN--(BUSINESS WIRE)--ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call.
ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference
DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference.